BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16870177)

  • 1. Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53.
    Ortt K; Sinha S
    FEBS Lett; 2006 Aug; 580(18):4544-50. PubMed ID: 16870177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm.
    Perez CA; Ott J; Mays DJ; Pietenpol JA
    Oncogene; 2007 Nov; 26(52):7363-70. PubMed ID: 17563751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.
    Yang A; Zhu Z; Kapranov P; McKeon F; Church GM; Gingeras TR; Struhl K
    Mol Cell; 2006 Nov; 24(4):593-602. PubMed ID: 17188034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach.
    Birkaya B; Ortt K; Sinha S
    BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 and epithelial biology.
    Barbieri CE; Pietenpol JA
    Exp Cell Res; 2006 Apr; 312(6):695-706. PubMed ID: 16406339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distance constraints and stereospecific alignment requirements characteristic of p53 DNA-binding consensus sequence homologies.
    Cook JL; Ré RN; Giardina JF; Fontenot FE; Cheng DY; Alam J
    Oncogene; 1995 Aug; 11(4):723-33. PubMed ID: 7651736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of p63 and p53 expression in tissue microarrays of malignant melanomas.
    Brinck U; Ruschenburg I; Di Como CJ; Buschmann N; Betke H; Stachura J; Cordon-Cardo C; Korabiowska M
    Int J Mol Med; 2002 Dec; 10(6):707-11. PubMed ID: 12429996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63.
    Cai BH; Chao CF; Lu MH; Lin HC; Chen JY
    J Biochem; 2012 Jul; 152(1):99-110. PubMed ID: 22577164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-conformation is an important determinant of sequence-specific DNA binding by tumor suppressor p53.
    Kim E; Albrechtsen N; Deppert W
    Oncogene; 1997 Aug; 15(7):857-69. PubMed ID: 9266973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of a consensus binding site for p53.
    el-Deiry WS; Kern SE; Pietenpol JA; Kinzler KW; Vogelstein B
    Nat Genet; 1992 Apr; 1(1):45-9. PubMed ID: 1301998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation.
    Ichikawa T; Suenaga Y; Koda T; Ozaki T; Nakagawara A
    Oncogene; 2008 Jan; 27(4):409-20. PubMed ID: 17637746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of vitamin D receptor as a target of p63.
    Kommagani R; Caserta TM; Kadakia MP
    Oncogene; 2006 Jun; 25(26):3745-51. PubMed ID: 16462763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
    Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
    Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
    Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I
    Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63: Molecular complexity in development and cancer.
    Westfall MD; Pietenpol JA
    Carcinogenesis; 2004 Jun; 25(6):857-64. PubMed ID: 15033906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel AP-2 consensus DNA binding site.
    Gee MS; Sarkisian CJ; el-Deiry WS
    Biochem Biophys Res Commun; 1998 Feb; 243(1):307-16. PubMed ID: 9473523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.